Intelligent Bio Solutions Inc. (NASDAQ:INBS) on Wednesday announced that Managed Waste Service plans to implement INBS' Intelligent Fingerprinting Drug Screening System across its New South Wales ...

Customers identify in-house control, project flexibility, productivity, and cost reductions as key business benefits of fingerprint sweat-based drug testing Construction and manufacturing firms ...

Validation study targets sub-3-minute results to capture global roadside testing market and significantly reduce analysis time from 10 minutes ...

Construction logistics, security, and support specialist selects Intelligent Fingerprinting Drug Screening System to simplify and speed up workplace drug testing for its 450 employees and contractors ...

SMARTOX deployed over 50 INBS fingerprint drug screening readers, conducting 7,000 tests, as FDA clearance for U.S. expansion is pursued. Intelligent Bio Solutions Inc. (INBS) has announced ...

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, non-invasive drug screening ...

NEW YORK, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced an update on its growing footprint in the U.S. Forensic Use Only Market on Wednesday through its strategic partnership with SMARTOX. SMARTOX, ...

NEW YORK, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the "Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions, ...